1. |
Titulaer M J, Mccracken L, Gabilondo I, <italic>et al</italic>. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurology, 2013, 12(2): 157-165.
|
2. |
Lancaster E, Lai M, Peng X, <italic>et al</italic>. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurology, 2010, 9(1): 67-76.
|
3. |
Hoftberger R, Titulaer M J, Sabater L, <italic>et al</italic>. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology, 2013, 81(17): 1500-1506.
|
4. |
Scheffer I E, Berkovic S, Capovilla G, <italic>et al</italic>. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 512-521.
|
5. |
Guan HZ, Ren HT, Yang XZ, <italic>et al</italic>. Limbic encephalitis associated with anti-γ-aminobutyric acid B receptor antibodies: a case Series from China. Chinese Medical Journal, 2015, 128(22): 3023-3028.
|
6. |
中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识. 中华神经科杂志, 2017, 50(2): 91.
|
7. |
Graus F, Titulaer M J, Balu R, <italic>et al</italic>. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology, 2016, 15(4): 391-404.
|
8. |
关鸿志, 崔丽英. 抗体相关的中枢神经系统自身免疫性疾病: 探索与挑战. 中华神经科杂志, 2019, 52(2): 81.
|